Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-08-29
2008-12-09
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S012200, C530S300000, C530S326000
Reexamination Certificate
active
07462598
ABSTRACT:
The invention provides theta defensin analogs having antimicrobial activity. The invention also provides a method of reducing or inhibiting growth or survival of a microorganism in an environment capable of sustaining the growth or survival of the microorganism, comprising administering an effective amount of a theta defensin analog to the environment, thereby reducing or inhibiting the growth or survival of the microorganism.
REFERENCES:
patent: 4543252 (1985-09-01), Lehrer et al.
patent: 4659692 (1987-04-01), Lehrer et al.
patent: 4705777 (1987-11-01), Lehrer et al.
patent: 5242902 (1993-09-01), Murphy et al.
patent: 5324716 (1994-06-01), Selsted et al.
patent: 5422424 (1995-06-01), Selsted et al.
patent: 5459235 (1995-10-01), Selsted et al.
patent: 5464823 (1995-11-01), Lehrer
patent: 5547939 (1996-08-01), Selsted et al.
patent: 5633229 (1997-05-01), Kokrayakov et al.
patent: 5693486 (1997-12-01), Lehrer et al.
patent: 5708145 (1998-01-01), Lehrer et al.
patent: 5731149 (1998-03-01), Selsted et al.
patent: 5804553 (1998-09-01), Kokryakov et al.
patent: 5804558 (1998-09-01), Lehrer et al.
patent: 5821224 (1998-10-01), Selsted et al.
patent: 5840498 (1998-11-01), Selsted et al.
patent: 5844072 (1998-12-01), Selsted et al.
patent: 5889152 (1999-03-01), Kokryakov et al.
patent: 5916872 (1999-06-01), Chang et al.
patent: 5994306 (1999-11-01), Chang et al.
patent: 6043220 (2000-03-01), Chang et al.
patent: 6159936 (2000-12-01), Lehrer et al.
patent: 6307016 (2001-10-01), Lehrer et al.
patent: 6335318 (2002-01-01), Selsted et al.
patent: 6492328 (2002-12-01), Lehrer et al.
patent: 6514727 (2003-02-01), Selsted et al.
patent: 6653442 (2003-11-01), Chang et al.
patent: 6713078 (2004-03-01), Lehrer et al.
patent: 2003/0022829 (2003-01-01), Maury et al.
patent: WO 96/16075 (1996-05-01), None
patent: WO 97/08199 (1997-06-01), None
patent: WO 99/11663 (1999-03-01), None
patent: WO 99/13080 (1999-03-01), None
patent: WO 00/12842 (2000-05-01), None
patent: WO 03/105883 (2003-12-01), None
U.S. Appl. No. 10/009,317, filed May 2002, Selsted et al.
U.S. Appl. No. 11/316,316, filed Dec. 2005, Selsted et al.
Leonova, et al. Circular minidefensins and posttranslational generation of molecular diversity, Journal of Leukocyte Biology, Sep. 2001, vol. 70, pp. 461-464.
Ahmad et al., “Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity,”Biochemica et Biophysica Acta1237:109-114 (1995).
Bals et al., “Mouse β-Defensin 1 Is a Salt-Sensitive Antimicrobial Peptide Present in Epithelia of the Lung and Urogenital Tract,”Infect. Immun.66(3):1225-1232 (1998).
Blond et al., “The cyclic structure of microcin J25, a 21-residue peptide antibiotic formEscherichia coli,” Eur. J. Biochem.259:747-755 (1999).
Derua et al., “Analysis of the Disulfide Linkage Pattern In Circulin A and B, HIV-Inhibitory Macrocyclic Peptides,”Biochem. Biophys. Res. Commun.228:632-638 (1996).
Gålvez et al., “Purification and Amino Acid Composition of Peptide Antibiotic AS-48 Produced byStreptococcus(Enterococcus)faecalissubsp. liquefaciens S-48,”Antimicrob. Agents Chemother.33(4):437-441 (1989).
Goldman et al., “Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cyctic Fibrosis,”Cell88:553-560 (1997).
Gustafson et al., “Circulins A and B: Novel HIV-Inhibitory Macrocyclic Peptides from the Tropical Tree Chassalia parvifolia,”J. Amer. Chem. Soc.116:9337-9338 (1994).
Lehrer and Ganz, “Antimicrobial peptides in mammalian and insect host defence,”Current Opinion Immunol.11(1):23-27 (1999).
Lehrer et al., “Defensins: Endogenous Antibiotic Peptides of Animal Cells,”Cell64:229-230 (1991).
Munk et al., “The β-defensin, retrocyclin, inhibits HIV-1 entry,”AIDS Res. Hum. Retroviruses19(10):875-881 (2003).
Smith et al., “Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid,”Cell85:229-236 (1996).
Tam et al., “Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-β strand cystine knot framework,”Biochem. Biophys. Res. Commun.267(3):783-790 (2000).
Tang et al., “A cyclic antimicrobial peptide produced in primate leukocytes by the litigation of two truncated β-defensins,”Science286(5439):498-502 (1999).
Tang and Selsted, “Characterization of the Disulfide Motif in BNBD-12, and Antimicrobial β-Defensin Peptide from Bovine Neutrophils,”J. Biol. Chem.268:6649-6653 (1993).
Tran, Dat Q., “Isolation, synthesis, and biological properties of cyclic defensins: structure-activity relationships and comparison with protegrin PG-1” Dissertation, University of California, Irvine, Thesis Defense May 1, 2001.
Valore et al., “Human β-Defensin-1: An Antimicrobial Peptide of Urogenital Tissues,”J. Clin. Invest.101:1633-1642 (1998).
Wade et al., “All-D amino acid-containing channel-forming antibiotic peptides,”Proc. Natl. Acad. Sci. USA87:4761-4765 (1990).
Wu et al., “Protein trans-splicing by a split intein encoded in a split DnaE gene ofSynechocystissp. PCC6803,”Proc. Natl. Acad. Sci. USA95:9226-9231 (1998).
Zanetti et al., “Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain,”FEBS Lett.347:1-5 (1995).
Selsted Michael E.
Tran Dat Q.
Gupta Anish
Ha Julie
McDermott Will & Emery LLP
The Regents of the University of California
LandOfFree
Antimicrobial theta defensins, analogs thereof, and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimicrobial theta defensins, analogs thereof, and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial theta defensins, analogs thereof, and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4038951